Lawrence Kenyon

Insider Reports History

Entity
Individual
Location
C/O Outlook Therapeutics, Inc., 7 Clarke Drive, Cranbury, NJ
Signature
/s/ Lawrence Kenyon
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lawrence Kenyon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Outlook Therapeutics, Inc. Chief Financial Officer, Director Common Stock 5.95K $33.8K $5.69 Sep 26, 2024 Direct
Outlook Therapeutics, Inc. Chief Financial Officer, Director Stock Option (Right to Buy) 12.5K Mar 20, 2024 Direct

Insider Reports Filed by Lawrence Kenyon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OTLK Outlook Therapeutics, Inc. Sep 26, 2024 1 $28.4K 4 Sep 30, 2024 Chief Financial Officer, Director
OTLK Outlook Therapeutics, Inc. Mar 20, 2024 1 $0 4 Mar 22, 2024 CHIEF FINANCIAL OFFICER, Director